Affordable Access

deepdyve-link
Publisher Website

Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration.

Authors
  • Rezende, Flavio A1
  • Lapalme, Eric2
  • Qian, Cynthia X2
  • Smith, Lois E3
  • SanGiovanni, John Paul4
  • Sapieha, Przemyslaw2
  • 1 Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada. Electronic address: [email protected] , (Canada)
  • 2 Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada. , (Canada)
  • 3 Department of Ophthalmology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts.
  • 4 Clinical Trials Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Type
Published Article
Journal
American journal of ophthalmology
Publication Date
November 2014
Volume
158
Issue
5
Pages
1071–1078
Identifiers
DOI: 10.1016/j.ajo.2014.07.036
PMID: 25089351
Source
Medline
License
Unknown

Abstract

This study demonstrated that omega-3 supplementation combined with anti-VEGF treatment is associated with decreased vitreal VEGF-A levels in wet AMD patients.

Report this publication

Statistics

Seen <100 times